Ian E. Smith

31.5k total citations · 6 hit papers
354 papers, 20.8k citations indexed

About

Ian E. Smith is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ian E. Smith has authored 354 papers receiving a total of 20.8k indexed citations (citations by other indexed papers that have themselves been cited), including 197 papers in Oncology, 127 papers in Cancer Research and 81 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ian E. Smith's work include Breast Cancer Treatment Studies (107 papers), HER2/EGFR in Cancer Research (69 papers) and Estrogen and related hormone effects (68 papers). Ian E. Smith is often cited by papers focused on Breast Cancer Treatment Studies (107 papers), HER2/EGFR in Cancer Research (69 papers) and Estrogen and related hormone effects (68 papers). Ian E. Smith collaborates with scholars based in United Kingdom, United States and Australia. Ian E. Smith's co-authors include Mitch Dowsett, Jorge S. Reis‐Filho, William D. Foulkes, John M. Shneerson, Janine Salter, Ander Urruticoechea, Geraldine Walsh, Roger A’Hern, Mary O’Brien and S. Ashley and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Ian E. Smith

345 papers receiving 20.1k citations

Hit Papers

Triple-Negative Breast Cancer 2003 2026 2010 2018 2010 2015 2003 2005 2005 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Triple-Negative Breast Cancer
    2010 3.1k citations William D. Foulkes, Ian E. Smith et al. New England Journal of Medicine profile →
  2. Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
    2015 814 citations Gaia Schiavon, Maggie C.U. Cheang et al. profile →
  3. Aromatase Inhibitors in Breast Cancer
    2003 678 citations Ian E. Smith, Mitch Dowsett New England Journal of Medicine profile →
  4. Proliferation Marker Ki-67 in Early Breast Cancer
    2005 656 citations Ian E. Smith, Mitch Dowsett et al. Journal of Clinical Oncology profile →
  5. Neoadjuvant Treatment of Postmenopausal Breast Cancer With Anastrozole, Tamoxifen, or Both in Combination: The Immediate Preoperative Anastrozole, Tamoxifen, or Combined With Tamoxifen (IMPACT) Multicenter Double-Blind Randomized Trial
    2005 549 citations Ian E. Smith, Mitch Dowsett et al. Journal of Clinical Oncology profile →
  6. Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer
    2015 416 citations Gaia Schiavon, Ashutosh Nerurkar et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian E. Smith United Kingdom 71 11.1k 8.4k 5.8k 4.4k 3.8k 354 20.8k
James N. Ingle United States 74 13.9k 1.2× 9.4k 1.1× 5.6k 1.0× 4.0k 0.9× 7.9k 2.1× 365 23.6k
Alan S. Coates Australia 76 14.4k 1.3× 11.0k 1.3× 3.7k 0.6× 4.3k 1.0× 4.9k 1.3× 297 23.6k
Karen A. Gelmon Canada 73 15.9k 1.4× 7.0k 0.8× 5.6k 1.0× 6.6k 1.5× 2.6k 0.7× 393 23.8k
Stephen E. Jones United States 67 10.1k 0.9× 4.7k 0.6× 2.2k 0.4× 4.7k 1.1× 3.4k 0.9× 358 20.4k
Meredith M. Regan United States 64 6.7k 0.6× 6.6k 0.8× 4.5k 0.8× 7.8k 1.8× 2.5k 0.6× 331 18.4k
Roger A’Hern United Kingdom 75 9.4k 0.8× 5.4k 0.6× 3.7k 0.6× 5.2k 1.2× 2.5k 0.7× 282 20.5k
Edith A. Perez United States 79 20.7k 1.9× 11.1k 1.3× 6.6k 1.1× 5.8k 1.3× 4.4k 1.2× 400 30.1k
Vicente Valero United States 94 17.3k 1.6× 13.2k 1.6× 5.4k 0.9× 4.9k 1.1× 2.2k 0.6× 500 27.9k
Vera J. Suman United States 60 7.0k 0.6× 3.6k 0.4× 3.0k 0.5× 2.3k 0.5× 2.2k 0.6× 273 14.8k
Sandra M. Swain United States 66 15.4k 1.4× 7.2k 0.9× 5.1k 0.9× 4.8k 1.1× 1.5k 0.4× 337 23.4k

Countries citing papers authored by Ian E. Smith

Since Specialization
Citations

This map shows the geographic impact of Ian E. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian E. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian E. Smith more than expected).

Fields of papers citing papers by Ian E. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian E. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian E. Smith. The network helps show where Ian E. Smith may publish in the future.

Co-authorship network of co-authors of Ian E. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Ian E. Smith. A scholar is included among the top collaborators of Ian E. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian E. Smith. Ian E. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Okines, Alicia, Kabir Mohammed, Peter Osin, et al.. (2022). Clinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experience. Breast Cancer Research and Treatment. 192(3). 563–571. 3 indexed citations
2.
Leal, Mariana Ferreira, Ben P. Haynes, Eugene F. Schuster, et al.. (2019). Early Enrichment of ESR1 Mutations and the Impact on Gene Expression in Presurgical Primary Breast Cancer Treated with Aromatase Inhibitors. Clinical Cancer Research. 25(24). 7485–7496. 13 indexed citations
3.
Partridge, Ann H., R. Bryan Rumble, Lisa A. Carey, et al.. (2014). Chemotherapy and Targeted Therapy for Women With Human Epidermal Growth Factor Receptor 2–Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology. 32(29). 3307–3329. 194 indexed citations
4.
Dunbier, Anita K., Zara Ghazoui, H Anderson, et al.. (2013). Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance. Clinical Cancer Research. 19(10). 2775–2786. 98 indexed citations
5.
Ewertz, Marianne, Kathryn P. Gray, Meredith M. Regan, et al.. (2012). Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial. Journal of Clinical Oncology. 30(32). 3967–3975. 102 indexed citations
6.
Schiavon, Gaia, Diana Tait, Tim Briggs, & Ian E. Smith. (2012). A Solitary Bone Lesion in a Patient With Previous Breast Cancer and the Importance of Bone Biopsy: A Case Report and a Review of Guidelines. Clinical Breast Cancer. 13(1). 77–80. 2 indexed citations
7.
Ghazoui, Zara, Francesca M. Buffa, Anita K. Dunbier, et al.. (2011). Close and Stable Relationship between Proliferation and a Hypoxia Metagene in Aromatase Inhibitor–Treated ER-Positive Breast Cancer. Clinical Cancer Research. 17(9). 3005–3012. 26 indexed citations
8.
Dunbier, Anita K., H Anderson, Zara Ghazoui, et al.. (2011). Association between breast cancer subtypes and response to neoadjuvant anastrozole. Steroids. 76(8). 736–740. 37 indexed citations
9.
Banerjee, Susana & Ian E. Smith. (2010). Management of small HER2-positive breast cancers. The Lancet Oncology. 11(12). 1193–1199. 42 indexed citations
10.
Foulkes, William D., Ian E. Smith, & Jorge S. Reis‐Filho. (2010). Triple-Negative Breast Cancer. New England Journal of Medicine. 363(20). 1938–1948. 3132 indexed citations breakdown →
11.
Haynes, Ben P., Anne Hege Straume, Jürgen Geisler, et al.. (2010). Intratumoral Estrogen Disposition in Breast Cancer. Clinical Cancer Research. 16(6). 1790–1801. 75 indexed citations
12.
Graeser, Monika, Afshan McCarthy, Christopher J. Lord, et al.. (2010). A Marker of Homologous Recombination Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Primary Breast Cancer. Clinical Cancer Research. 16(24). 6159–6168. 222 indexed citations
13.
Arnedos, Mónica, Ashutosh Nerurkar, Peter Osin, et al.. (2009). Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC). Annals of Oncology. 20(12). 1948–1952. 142 indexed citations
14.
Dowsett, Mitch, Roger A’Hern, Janine Salter, Lila Zabaglo, & Ian E. Smith. (2009). Who would have thought a single Ki67 measurement would predict long-term outcome?. Breast Cancer Research. 11(S3). S15–S15. 17 indexed citations
15.
Smith, Ian E., Geraldine Walsh, Anthony Skene, et al.. (2007). A Phase II Placebo-Controlled Trial of Neoadjuvant Anastrozole Alone or With Gefitinib in Early Breast Cancer. Journal of Clinical Oncology. 25(25). 3816–3822. 169 indexed citations
16.
Arriola, Edurne, Socorro Marıá Rodríguez-Pinilla, Maryou B. Lambros, et al.. (2007). Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancer. Breast Cancer Research and Treatment. 106(2). 181–189. 87 indexed citations
17.
Quinnell, Timothy, I. Sadaf Farooqi, Ian E. Smith, & John M. Shneerson. (2007). Screening the human prepro-orexin gene in a single-centre narcolepsy cohort. Sleep Medicine. 8(5). 498–502. 3 indexed citations
18.
Dowsett, Mitch, J. Michael Dixon, Anthony Skene, et al.. (2005). Biomarker Changes During Neoadjuvant Anastrozole, Tamoxifen, or the Combination: Influence of Hormonal Status and HER-2 in Breast Cancer—A Study from the IMPACT Trialists. Journal of Clinical Oncology. 23(11). 2477–2492. 229 indexed citations
19.
Highcock, Martin, J M Shneerson, & Ian E. Smith. (2001). Functional differences in bi-level pressure preset ventilators. European Respiratory Journal. 17(2). 268–273. 33 indexed citations
20.
Vincent, Mark, H.M. Clink, R. Charles Coombes, et al.. (1985). Aminoglutethimide (with hydrocortisone) induced agranulocytosis in primary breast cancer.. BMJ. 291(6488). 105.2–106. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James N. Ingle Breakdown of academic impact, for papers by Alan S. Coates Breakdown of academic impact, for papers by Karen A. Gelmon Breakdown of academic impact, for papers by Stephen E. Jones Breakdown of academic impact, for papers by Meredith M. Regan Breakdown of academic impact, for papers by Roger A’Hern Breakdown of academic impact, for papers by Edith A. Perez Breakdown of academic impact, for papers by Vicente Valero Breakdown of academic impact, for papers by Vera J. Suman Breakdown of academic impact, for papers by Sandra M. Swain
Rankless by CCL
2026